News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Athersys, Inc. Announces Grant to Support Clinical Advancement of Its MultiStem® Regenerative Medicine Program for Heart Attack Patients


8/6/2013 9:59:40 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CLEVELAND, Aug. 6, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has received a SBIR Fast Track grant from the National Heart, Lung, and Blood Institute, which will support a Phase 2 clinical study evaluating the administration of MultiStem® therapy to patients who have suffered a heart attack, or acute myocardial infarction (AMI). The grant is expected to provide up to $2.8 million in support over the course of the study in connection with study progress and milestone achievement.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES